Kerrest Jacques Frederic

Director Kerrest Jacques Frederic sells 313,863 shares (313.9K) of OKTA across 12 transactions for $34.0M at blended $108.20, holding zero shares post-sale

Director Kerrest Jacques Frederic executed 12 separate sales totaling 313,863 shares for $33,959,605.50 across March 4-5, 2025, at prices ranging from $103.50 to $112.50 and a blended average of $108.20. The filing includes a conversion of derivative securities, meaning Table I holdings do not represent the insider's total position—this sale is a specific batch liquidation, not necessarily a complete exit from all derivative holdings. The stock has appreciated 17.8% over 30 days and 31.2% over 90 days, trading at $111.22 currently (-4.4% from the 52-week high of $116.31), while the company reports strong fundamentals with annual revenue growth of +15.3%, though a P/E of 695.12 reflects elevated valuation. The insider has conducted multiple sales at OKTA within the prior three weeks (February 5 and February 13), establishing a pattern of recent sequential transactions at this ticker.

Director Kerrest Jacques Frederic sells 74,999 shares (75.0K) at $100.50 for $7,537,399.50 ($7.5M); converts derivative holdings.

Director Kerrest Jacques Frederic executed 3 separate sales totaling 74,999 (75.0K shares) for $7,537,399.50 ($7.5M) on 2025-02-13, following prior sales on 2025-02-05 and 2025-01-28. The filing indicates a derivative-conversion transaction; the insider's remaining position lives in Table II (derivative securities) and is not yet populated in the database, so this does not represent a complete liquidation. The sales occurred at $100.50, above the current price of $97.04 and within the 52-week range ($71.00–$111.49). Okta's fundamentals show revenue of $665,000,000.00 and net income of $16,000,000.00 in the latest quarter, with annual revenue growth of +21.8%, though the company reported negative full-year net income on a full-fiscal-year basis. The insider has 20 prior open-market sells across all tickers in his track record; across his 5 prior OKTA trades, outcomes are not yet measurable.

Director Kerrest Jacques Frederic sold 74,999 shares of OKTA for $7.3M at $97.50 on Feb 5, 2025

Director Kerrest Jacques Frederic executed 3 separate sales totaling 74,999 shares for $7,312,402.50 on 2025-02-05 at a blended average price of $97.50, eliminating his common share holdings. The transaction occurs amid strong recent stock performance: OKTA has gained 13.5% over the past 30 days and 26.4% over 90 days, trading at $97.00 versus a 52-week high of $111.49. However, a FLAG in the filing indicates this involves a conversion of derivative securities—the insider's total economic position extends beyond the Table I common shares shown here and is documented in the as-yet unpopulated Table II derivative holdings. The company posted $665.0M in quarterly revenue with 21.8% annual growth, though it remains unprofitable on a full-year basis. Investors should examine the derivative conversion structure to understand the insider's complete transaction scope and ongoing exposure.

Director Kerrest Jacques Frederic sold 149,998 shares of OKTA for $13.9M in 6 transactions at $93.00 blended average on 2025-01-28.

Director Kerrest Jacques Frederic executed 6 separate sales totaling 149,998 shares for $13,949,814.00 at a blended average price of $93.00 on 2025-01-28. This transaction involved a conversion of derivative securities (Form 4 Table II), and the insider's full position includes holdings beyond the Table I shares reported here; therefore this represents a partial sale of a specific batch rather than a complete position exit. The sale occurs within a recent cluster of OKTA sales (5 prior trades on 2025-01-23 and 2025-01-24 at this same ticker), suggesting active portfolio management. The insider's cross-ticker track record shows a 100% well-timed rate at the 90-day mark across 20 prior sales (average 90-day return -22.2%), though same-ticker outcomes at OKTA are not yet measurable. The stock is trading near recent highs relative to its 52-week range and has appreciated 19.0% over the past 30 days and 28.0% over 90 days, though it remains 15.9% below its 52-week high of $111.49.

Director Kerrest Jacques Frederic sells 524,993 shares of OKTA for $45,826,688.45 across 12 transactions (Jan 23-24)

Kerrest Jacques Frederic, a Director at Okta, executed 12 separate sales totaling 524,993 shares for $45,826,688.45 on January 23-24, 2025, at a blended average price of $87.29. The filing includes a derivative-conversion flag, indicating these shares originated from the conversion of derivative securities; the insider's residual position in unconverted derivatives is not yet populated in the database and should not be assumed zero. This sale represents the disposition of a specific converted batch rather than a complete position exit. The transaction occurs in a company with strong recent momentum (up 23.2% over 90 days, up 11.3% over 30 days) and solid revenue growth of 21.8% year-over-year, though the company reported negative full-year net income in its most recent fiscal year. Across his cross-ticker track record, this insider's prior sells have been well-timed 100.0% of the time at the 90-day mark; however, his recent same-ticker activity at OKTA (5 prior trades, mostly from December 2024) shows modest headwinds—averaging -2.8% over 30 days—with only 1 of 1 prior measurable same-ticker sells showing well-timed outcomes.

Director Kerrest Jacques Frederic sells 169,335 shares for $13.7M; retains 1,622 shares post-transaction

Director Kerrest Jacques Frederic executed 4 separate sales totaling 169,335 shares for $13,651,719.19 at a blended average price of $80.62 on December 2–3, 2024. This sale reduced his shareholding by 99.1% from 170,957 to 1,622 shares. The transaction occurred when OKTA stock was trading 22.8% below its 52-week high of $111.49, but up 17.6% over the prior 30 days. Across his prior 5 trades at OKTA, all proved well-timed at the 90-day mark (average 90d return: -21.2%), establishing a pattern of selling before subsequent declines. However, this filing contains a derivative-conversion transaction—the Form 4 Table II derivative securities holding is not yet populated in the database, so the 1,622 shares_after may not represent his full economic position. The company posted $665.0M quarterly revenue with annual growth of 21.8%, though it remains unprofitable on a full-year basis (negative net income).

Director Kerrest Jacques Frederic sold 26,618 shares of OKTA at $100.29 (July 16), reducing derivative-backed position; stock now -15.8% from 52-week high.

Director Kerrest Jacques Frederic sold 26,618 shares at $100.29 on 2024-07-16, reducing his stake from 26.6K shares to 0 in this derivative-conversion transaction. The sale occurred near the stock's 52-week high of $111.49 and is now -15.8% from that peak, with the current price at $93.92 representing a 6.4% decline from the sale price. This filing reflects a conversion of derivative securities rather than a full position liquidation, and his prior trading at OKTA shows a pattern of recent sales (four trades in June-July 2024) that have captured positive near-term returns of 5.6%–6.7% in their 30-day windows. The company remains unprofitable on a full-year basis with net income of $-40.0M, though it reported strong annual revenue growth of +21.8% and most recent quarterly revenue of $617.0M.

Director Kerrest Jacques Frederic sells 34,620 shares for $3.3M at OKTA (two transactions: 16,783 @ $95.84, 17,837 @ $96.24)

Kerrest Jacques Frederic, as a Director at Okta, executed two separate sales totaling 34,620 shares for $3,325,064.52, with a blended average price of $96.04 on 2024-07-05. The current price of $94.64 sits 15.1% below the 52-week high of $111.49, and the stock has gained 8.3% over the past 30 days. The company reported $617,000,000 in latest quarter revenue with annual growth of 21.8%, but remains unprofitable with a net loss of $-40,000,000 over its most recent full fiscal year. This filing contains a derivative-conversion transaction; the director's remaining holdings in derivative securities (Form 4 Table II) are not yet available in our database, so this sale should not be characterized as a complete position exit. The transactions occurred at valuations moderately above current market levels, in an unprofitable but growing company context.